In Brief: Organon Remeron
Executive Summary
Organon Remeron: Will be discussed at a meeting of FDA's Psychopharmacologic Drugs Advisory Committee on Oct. 16 at 8:30 a.m. in Parklawn Conference Rooms D & E. Remeron (mirtazapine, NDA 20-415) is being studied for depression...